Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cns Pharmaceuticals Inc
(NQ:
CNSP
)
0.1660
-0.0040 (-2.35%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cns Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
BioMedNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Distinguished with Unique Capabilities
August 07, 2023
Via
Investor Brand Network
Exposures
COVID-19
CNS Pharma's Lead Drug Candidate Crosses The Blood Brain Barrier - What Does That Mean? Watch the full show here!
August 07, 2023
Watch the full show here! John Climaco, Chairman & CEO of CNS Pharmaceuticals (NASDAQ: CNSP) presented at Benzinga’s webinar: Pharma Companies Vs. A Tough Macro Backdrop.
Via
Benzinga
Researchers Unlock Previously Unknown Weakness of Brain Cancer
August 04, 2023
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports on Berubicin Pivotal Study, Announces Participation in Biotech Conference
August 03, 2023
Via
Investor Brand Network
CNS Pharmaceuticals to Present at Benzinga's Virtual Biotech Conference
August 03, 2023
Via
ACCESSWIRE
Researchers Trace Glioma Brain Tumor Origins to Epigenome
July 31, 2023
Via
Investor Brand Network
CNS Pharmaceuticals Provides Clinical Trial Update for Ongoing Potentially Pivotal Study with Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
August 03, 2023
Via
ACCESSWIRE
BioMedNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Abstract Selected for Poster Presentation at 2023 SNO/ASCO CNS Cancer Conference
July 27, 2023
Via
Investor Brand Network
CNS Pharmaceuticals (NASDAQ:CNSP) Announces Acceptance of Abstract for Poster Presentation at the 2023 SNO/ASCO CNS Cancer Conference
July 27, 2023
Via
ACCESSWIRE
Clinical Trial Testing Modified Viruses as Brain Cancer Treatment Begins
July 25, 2023
Via
Investor Brand Network
National GBM Awareness Events Underscore Significance of Clinical Trial Progress for CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)
July 21, 2023
Via
Investor Brand Network
CNS Pharmaceuticals to Participate in the Virtual Investor Summer Spotlight Series
July 05, 2023
Via
ACCESSWIRE
CNS Pharmaceuticals (NASDAQ:CNSP) to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest
June 14, 2023
Via
ACCESSWIRE
Doctors Use Melanoma Drugs to Shrink Brain Tumors by 90% in Small Study
July 19, 2023
Via
Investor Brand Network
Harvard Scientists Create AI Tool to Provide Real-Time Genetic Analysis of Brain Cancer During Surgery
July 14, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Biochemist Working to Make Chemo Sans Side Effects
July 07, 2023
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation in July’s Virtual Investor Summer Spotlight Series
July 05, 2023
Via
Investor Brand Network
Immunotherapy Implants Could Turn Tumor Cells on Each Other
June 30, 2023
Via
Investor Brand Network
Virus Therapy Plus Radiation Could Improve Brain Tumor Treatment, Study Finds
June 26, 2023
Via
Investor Brand Network
Experimental Vaccine Brings Hope of Slowing Glioblastoma Tumor Regrowth
June 20, 2023
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation in Upcoming Maxim Group Virtual Healthcare Conference
June 15, 2023
Via
Investor Brand Network
Researchers Explain How Brain Cancers Hijack Neural Circuits
June 13, 2023
Via
Investor Brand Network
Scientists Create Open-Source Platform to Analyze Brain Tumors in Kids
June 07, 2023
Via
Investor Brand Network
Biotechs Zeroing In on Developing Breakthrough Therapeutics for Metastatic Breast Cancer
June 05, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:GILD),(NASDAQ:RAIN),(NASDAQ:CNSP),(NYSE:BMY) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
12 Health Care Stocks Moving In Friday's Intraday Session
June 02, 2023
Via
Benzinga
Study Shows Brain Cancer Among Top Cancer Types in US
June 01, 2023
Via
Investor Brand Network
Why Guidewire Software Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 02, 2023
Gainers MultiMetaVerse Holdings Limited (NASDAQ: MMV) gained 236% to $3.1592 after the company announced it signed a non-binding term sheet to acquire an equity stake in Taomee group.
Via
Benzinga
Proton Beam Therapy Could Boost Quality of Life for Cancer Patients
May 25, 2023
Via
Investor Brand Network
Topics
Death
Exposures
Death
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Achieves 50%+ Enrollment in Potentially Pivotal Berubicin Study
May 25, 2023
Via
Investor Brand Network
CNS Pharmaceuticals (NASDAQ:CNSP) Achieves Over 50% Completion of Enrollment in Potentially Pivotal Study with Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
May 25, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.